Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Martin

Showing results (471-480 of 692) with videos related to

Pageof 70
Sort By:
NPJ Vaccines|July 30, 2021
Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine virusesRahnuma Wahid, Laina Mercer, Andrew Macadam, et al.
Signal Transduction and Targeted Therapy|October 24, 2023
Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/ CDKN2AJavier Martin-Broto, Jeronimo Martinez-Garcia, David S Moura, et al.
Annals of the Rheumatic Diseases|May 26, 2019
Low RUNX3 expression alters dendritic cell function in patients with systemic sclerosis and contributes to enhanced fibrosisAlsya J Affandi, Tiago Carvalheiro, Andrea Ottria, et al.
JAMA Cardiology|April 21, 2021
Cardiovascular Biomarkers in the Early Discrimination of Type 2 Myocardial InfarctionThomas Nestelberger, Jasper Boeddinghaus, Pedro Lopez-Ayala, et al.
Medrxiv : the Preprint Server for Health Sciences|February 26, 2024
A genome-wide association study suggests new susceptibility loci for primary antiphospholipid syndromeDesiré Casares-Marfil, Manuel Martínez-Bueno, Maria Orietta Borghi, et al.
The Oncologist|November 10, 2018
Relevance of Reference Centers in Sarcoma Care and Quality Item Evaluation: Results from the Prospective Registry of the Spanish Group for Research in Sarcoma (GEIS)Javier Martin-Broto, Nadia Hindi, Josefina Cruz, et al.
Cancer|November 14, 2024
Nivolumab and sunitinib in patients with advanced bone sarcomas: A multicenter, single-arm, phase 2 trialEmanuela Palmerini, Antonio Lopez Pousa, Giovanni Grignani, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 8, 2024
A Genome-Wide Association Study Suggests New Susceptibility Loci for Primary Antiphospholipid SyndromeDesiré Casares-Marfil, Manuel Martínez-Bueno, Maria Orietta Borghi, et al.
Cancers|May 6, 2020
<i>CUL4A</i>, <i>ERCC5</i>, and <i>ERCC1</i> as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) StudyDavid S Moura, Paloma Sanchez-Bustos, Antonio Fernandez-Serra, et al.
ESMO Open|January 21, 2020
Familial adenomatosis polyposis-related desmoid tumours treated with low-dose chemotherapy: results from an international, multi-institutional, retrospective analysisAndrea Napolitano, Salvatore Provenzano, Chiara Colombo, et al.
Pageof 70

Showing results (471-480 of 692) with videos related to

Sort By:
Pageof 70
NPJ Vaccines|July 30, 2021
Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine virusesRahnuma Wahid, Laina Mercer, Andrew Macadam, et al.
Signal Transduction and Targeted Therapy|October 24, 2023
Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/ CDKN2AJavier Martin-Broto, Jeronimo Martinez-Garcia, David S Moura, et al.
Annals of the Rheumatic Diseases|May 26, 2019
Low RUNX3 expression alters dendritic cell function in patients with systemic sclerosis and contributes to enhanced fibrosisAlsya J Affandi, Tiago Carvalheiro, Andrea Ottria, et al.
JAMA Cardiology|April 21, 2021
Cardiovascular Biomarkers in the Early Discrimination of Type 2 Myocardial InfarctionThomas Nestelberger, Jasper Boeddinghaus, Pedro Lopez-Ayala, et al.
Medrxiv : the Preprint Server for Health Sciences|February 26, 2024
A genome-wide association study suggests new susceptibility loci for primary antiphospholipid syndromeDesiré Casares-Marfil, Manuel Martínez-Bueno, Maria Orietta Borghi, et al.
The Oncologist|November 10, 2018
Relevance of Reference Centers in Sarcoma Care and Quality Item Evaluation: Results from the Prospective Registry of the Spanish Group for Research in Sarcoma (GEIS)Javier Martin-Broto, Nadia Hindi, Josefina Cruz, et al.
Cancer|November 14, 2024
Nivolumab and sunitinib in patients with advanced bone sarcomas: A multicenter, single-arm, phase 2 trialEmanuela Palmerini, Antonio Lopez Pousa, Giovanni Grignani, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 8, 2024
A Genome-Wide Association Study Suggests New Susceptibility Loci for Primary Antiphospholipid SyndromeDesiré Casares-Marfil, Manuel Martínez-Bueno, Maria Orietta Borghi, et al.
Cancers|May 6, 2020
<i>CUL4A</i>, <i>ERCC5</i>, and <i>ERCC1</i> as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) StudyDavid S Moura, Paloma Sanchez-Bustos, Antonio Fernandez-Serra, et al.
ESMO Open|January 21, 2020
Familial adenomatosis polyposis-related desmoid tumours treated with low-dose chemotherapy: results from an international, multi-institutional, retrospective analysisAndrea Napolitano, Salvatore Provenzano, Chiara Colombo, et al.
Pageof 70